WO2018097540A3 - 무혈청면역세포배양용 배지첨가키트, 상기 키트를 이용한 면역세포배양방법, 상기 키트 또는 배양방법에 의해 얻어진 무혈청면역세포배양액 및 상기 배양액을 포함하는 화장료조성물 - Google Patents
무혈청면역세포배양용 배지첨가키트, 상기 키트를 이용한 면역세포배양방법, 상기 키트 또는 배양방법에 의해 얻어진 무혈청면역세포배양액 및 상기 배양액을 포함하는 화장료조성물 Download PDFInfo
- Publication number
- WO2018097540A3 WO2018097540A3 PCT/KR2017/013020 KR2017013020W WO2018097540A3 WO 2018097540 A3 WO2018097540 A3 WO 2018097540A3 KR 2017013020 W KR2017013020 W KR 2017013020W WO 2018097540 A3 WO2018097540 A3 WO 2018097540A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- culturing
- kit
- serum
- same
- immune cell
- Prior art date
Links
- 238000012258 culturing Methods 0.000 title abstract 9
- 238000000034 method Methods 0.000 title abstract 6
- 210000002865 immune cell Anatomy 0.000 title abstract 5
- 238000004113 cell culture Methods 0.000 title abstract 2
- 239000002537 cosmetic Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 210000000822 natural killer cell Anatomy 0.000 abstract 4
- 230000003213 activating effect Effects 0.000 abstract 1
- 238000010241 blood sampling Methods 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0031—Serum-free culture media
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2301—Interleukin-1 (IL-1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2312—Interleukin-12 (IL-12)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2315—Interleukin-15 (IL-15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2318—Interleukin-18 (IL-18)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/515—CD3, T-cell receptor complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
- C12N2502/1164—NK cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 면역요법에 적용되는 자연살해세포(Natural Killer cell; NK 세포) 배양기술에 관한 것으로, 보다 구체적으로는 종래의 면역세포배양방법과 비교하여 채혈한지 하루 이상 지나거나 많이 약해져 있는 면역세포 일지라도 효율적으로 증폭 및 활성화시키는 동시에 NK세포가 차지하는 비율을 현저하게 증가시켜 배양할 수 있는 무혈청면역세포배양용 배지첨가키트, 상기 키트를 이용한 면역세포배양방법, 상기 키트 또는 배양방법에 의해 얻어진 무혈청면역세포배양액 및 상기 배양액을 포함하는 화장료조성물에 대한 것이다.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17872943.0A EP3546570A4 (en) | 2016-11-22 | 2017-11-16 | KIT WITH MEDIUM FOR THE CULTURE OF SERUM-FREE IMMUNELL CELLS, METHOD FOR THE CULTURE OF IMMUNAL CELLS BY USE OF THE KIT, SERUM-FREE IMMUNE CELL CULTURE RECEIVED BY THE KIT OR CULTURE METHOD AND COSMETIC COMPOSITION |
JP2019528438A JP2019535293A (ja) | 2016-11-22 | 2017-11-16 | 無血清免疫細胞培養培地添加キット、そのキットを使用することによって免疫細胞を培養するための方法、そのキットにより得られた無血清免疫細胞培養物又は培養方法、及びその培養物を含む化粧用組成物 |
CN201780083599.1A CN110214179A (zh) | 2016-11-22 | 2017-11-16 | 免疫细胞无血清培养用培养基添加试剂盒、使用该试剂盒的免疫细胞培养方法、通过该试剂盒或培养方法获得的免疫细胞无血清培养液以及包含该培养液的化妆材料组合物 |
US16/420,115 US20190276803A1 (en) | 2016-11-22 | 2019-05-22 | Method of culturing immune cells, kit for thereof, immune cell cultured medium obtained by same method, cosmetic composition and pharmaceutical composition comprising thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160155890A KR101969045B1 (ko) | 2016-11-22 | 2016-11-22 | 면역세포배양용 배지첨가키트, 상기 키트를 이용한 면역세포배양방법, 상기 키트 또는 배양방법에 의해 얻어진 무혈청면역세포배양액 및 상기 배양액을 포함하는 화장료조성물 |
KR10-2016-0155890 | 2016-11-22 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/420,115 Continuation-In-Part US20190276803A1 (en) | 2016-11-22 | 2019-05-22 | Method of culturing immune cells, kit for thereof, immune cell cultured medium obtained by same method, cosmetic composition and pharmaceutical composition comprising thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2018097540A2 WO2018097540A2 (ko) | 2018-05-31 |
WO2018097540A3 true WO2018097540A3 (ko) | 2019-01-24 |
WO2018097540A9 WO2018097540A9 (ko) | 2019-03-21 |
Family
ID=62195266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2017/013020 WO2018097540A2 (ko) | 2016-11-22 | 2017-11-16 | 무혈청면역세포배양용 배지첨가키트, 상기 키트를 이용한 면역세포배양방법, 상기 키트 또는 배양방법에 의해 얻어진 무혈청면역세포배양액 및 상기 배양액을 포함하는 화장료조성물 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20190276803A1 (ko) |
EP (1) | EP3546570A4 (ko) |
JP (1) | JP2019535293A (ko) |
KR (1) | KR101969045B1 (ko) |
CN (1) | CN110214179A (ko) |
WO (1) | WO2018097540A2 (ko) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101683614B1 (ko) * | 2016-02-15 | 2016-12-07 | 신동혁 | Nk세포배양용 배지첨가키트 및 상기 키트를 이용한 nk세포배양방법 |
KR102014467B1 (ko) * | 2017-12-14 | 2019-08-26 | (주)녹십자웰빙 | 아토피성 피부염, 탈모, 상처 또는 피부 주름의 개선용 화장료 조성물 및 약학 조성물 |
KR102234394B1 (ko) | 2019-03-08 | 2021-03-31 | 신지섭 | 타가면역세포배양방법, 그 방법으로 얻어진 면역세포배양액 및 이를 포함하는 면역세포치료제 |
KR102216710B1 (ko) | 2019-03-27 | 2021-02-17 | 신지섭 | Nk세포배양배지용 첨가조성물, 상기 첨가조성물을 이용한 nk세포배양방법 및 상기 배양방법으로 얻어진 피부트러블개선용 화장료조성물 |
KR102233660B1 (ko) | 2019-05-15 | 2021-03-30 | (주)포에버엔케이 | 효율적 자연살해세포 배양방법 및 이의 배지첨가 키트 |
KR102087710B1 (ko) * | 2019-05-22 | 2020-03-11 | 주식회사 아리바이오 | 회전형 세포배양 장치를 이용한 nk 세포 활성과 증식 향상의 배양 방법 및 이에 생산된 nk 배양액의 용도 |
US11453862B2 (en) * | 2019-07-08 | 2022-09-27 | Immunitybio, Inc. | Mononuclear cell derived NK cells |
CN110305840A (zh) * | 2019-07-12 | 2019-10-08 | 赛德特生物科技开发有限公司 | 改善自身免疫疾病的免疫细胞培养基及其制备方法与应用 |
KR102218211B1 (ko) | 2020-05-04 | 2021-02-22 | 주식회사 이뮤니스바이오 | 조절 t 세포 배양액을 포함하는 상처치유용 조성물 |
KR102380211B1 (ko) * | 2020-06-04 | 2022-03-30 | 주식회사 이뮤니스바이오 | 면역세포배양액을 포함한 항균효과를 가지는 화장료 조성물 |
KR102541619B1 (ko) | 2020-08-24 | 2023-06-12 | ㈜ 엔케이씨엘바이오그룹 | 자연살해세포 활성도 신속검사용 자극조성물 및 이를 이용한 자연살해세포 활성도 신속검사방법 |
KR20220031462A (ko) | 2020-09-04 | 2022-03-11 | 신지섭 | 타가면역세포배양방법, 그 방법으로 얻어진 면역세포배양액 및 이를 포함하는 면역세포치료제 |
KR20220036327A (ko) | 2020-09-15 | 2022-03-22 | ㈜ 엔케이씨엘바이오그룹 | 면역세포증식활성화키트 및 상기 증식활성화키트를 이용한 면역세포배양방법 |
EP4230728A1 (en) | 2020-09-15 | 2023-08-23 | Shin, Ji-Seop | Immune cell proliferation/activation kit and immune cell culture method using same proliferation/activation kit |
KR102472076B1 (ko) | 2021-12-16 | 2022-11-30 | 주식회사 아리아코스메틱 | Nk세포 배양배지 조성물을 이용하여 제조되는 마이크로바이옴 유산균을 포함하는 화장료 제조방법 |
KR102504039B1 (ko) * | 2022-10-25 | 2023-03-02 | 오정훈 | 자연살해세포 증식에 효과적인 배양 방법 및 이의 용도 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090127973A (ko) * | 2008-06-10 | 2009-12-15 | 주식회사 엔케이바이오 | 자기활성화 림프구 배양 방법 |
WO2010013947A2 (ko) * | 2008-07-29 | 2010-02-04 | 주식회사 녹십자 | 자연살해세포의 증식방법 |
KR101039843B1 (ko) * | 2010-08-30 | 2011-06-09 | 주식회사 엔케이바이오 | 자기활성화 림프구 배양용 배지 조성물 및 이를 이용한 자기활성화 림프구 배양방법 |
KR20130047167A (ko) * | 2011-10-31 | 2013-05-08 | 이동욱 | 면역세포 증식 배양액이 함유된 화장료 조성물 제조방법 |
CN104357390A (zh) * | 2014-10-15 | 2015-02-18 | 深圳源正细胞医疗技术有限公司 | 同时高效扩增cd3+cd56+cik细胞和cd3-cd56+nk细胞的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101400787B (zh) * | 2006-01-27 | 2013-01-23 | 株式会社Prostemics | 采用脂肪来源成体干细胞大量制造生长因子的方法 |
KR20090127974A (ko) * | 2008-06-10 | 2009-12-15 | 주식회사 엔케이바이오 | 자기활성화 림프구 배양용 배지 조성물 |
EA201390314A1 (ru) * | 2010-09-09 | 2013-11-29 | Макрокьюэ, Лтд. | Супернатант, кондиционированный активированными лейкоцитами, и его использование для заживления ран |
CN105219708A (zh) * | 2015-07-21 | 2016-01-06 | 中山大学 | 免疫细胞培养试剂盒、免疫细胞培养方法和应用 |
CN105997835B (zh) * | 2016-05-11 | 2019-03-19 | 紫程瑞生会(北京)生物技术发展有限公司 | 一种免疫细胞来源的生物美容原料的制备方法及其产品 |
-
2016
- 2016-11-22 KR KR1020160155890A patent/KR101969045B1/ko active IP Right Grant
-
2017
- 2017-11-16 CN CN201780083599.1A patent/CN110214179A/zh active Pending
- 2017-11-16 JP JP2019528438A patent/JP2019535293A/ja active Pending
- 2017-11-16 EP EP17872943.0A patent/EP3546570A4/en not_active Withdrawn
- 2017-11-16 WO PCT/KR2017/013020 patent/WO2018097540A2/ko unknown
-
2019
- 2019-05-22 US US16/420,115 patent/US20190276803A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090127973A (ko) * | 2008-06-10 | 2009-12-15 | 주식회사 엔케이바이오 | 자기활성화 림프구 배양 방법 |
WO2010013947A2 (ko) * | 2008-07-29 | 2010-02-04 | 주식회사 녹십자 | 자연살해세포의 증식방법 |
KR101039843B1 (ko) * | 2010-08-30 | 2011-06-09 | 주식회사 엔케이바이오 | 자기활성화 림프구 배양용 배지 조성물 및 이를 이용한 자기활성화 림프구 배양방법 |
KR20130047167A (ko) * | 2011-10-31 | 2013-05-08 | 이동욱 | 면역세포 증식 배양액이 함유된 화장료 조성물 제조방법 |
CN104357390A (zh) * | 2014-10-15 | 2015-02-18 | 深圳源正细胞医疗技术有限公司 | 同时高效扩增cd3+cd56+cik细胞和cd3-cd56+nk细胞的方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2018097540A2 (ko) | 2018-05-31 |
JP2019535293A (ja) | 2019-12-12 |
EP3546570A2 (en) | 2019-10-02 |
KR101969045B1 (ko) | 2019-04-19 |
US20190276803A1 (en) | 2019-09-12 |
KR20180057359A (ko) | 2018-05-30 |
EP3546570A4 (en) | 2020-07-15 |
WO2018097540A9 (ko) | 2019-03-21 |
CN110214179A (zh) | 2019-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018097540A3 (ko) | 무혈청면역세포배양용 배지첨가키트, 상기 키트를 이용한 면역세포배양방법, 상기 키트 또는 배양방법에 의해 얻어진 무혈청면역세포배양액 및 상기 배양액을 포함하는 화장료조성물 | |
MX2022003477A (es) | Medio de cultivo celular complementado con taurina y metodos de uso. | |
AU2017261380A1 (en) | Genetically engineered cells and methods of making the same | |
EP4265261A3 (en) | Methods and compositions for inhibiting expression of ldha | |
EP3571230A4 (en) | COMPOSITIONS AND METHODS FOR DELETION OF CD137 + CELLS | |
EP3947642A4 (en) | CULTURE MEDIUM FOR MAMMALIAN PLURIPOTENTE STEM CELLS, COMPOSITION AND METHODS | |
AU2016250905A8 (en) | Generation of muscle-lineage cells from stem cells | |
MX2019011999A (es) | Metodo y usos de exudados encapsulados y biomasa seca de euglena para la union de metal. | |
EP3633029A4 (en) | PROCESS FOR CULTURING NATURAL KILLER CELLS USING A TRANSFORMED T LYMPHOCYTE | |
MX2021009554A (es) | Produccion de virus en cultivos celulares. | |
EP3892722A4 (en) | METHOD FOR PRODUCING T LYMPHOCYTES OR NK CELLS, MEDIUM FOR CULTIVATING T LYMPHOCYTES OR NK CELLS, METHOD FOR CULTURING T LYMPHOCYTES OR NK CELLS, METHOD FOR MAINTAINING THE UNDIFFERENTIATED STATE OF UNDIFFERENTIATED T LYMPHOCYTES, AND GROWTH ACCELERATION FOR T LYMPHOCYTES OR NK CELLS | |
EP3960154A4 (en) | FUNCTIONAL COMPOSITION CONTAINING AN EXOSOME-RICH CULTURE MEDIUM DERIVED FROM AN IMMORTALIZED STEM CELL AND ROSE BUD EXTRACT AS ACTIVE INGREDIENTS | |
EP3973048A4 (en) | COMPOSITIONS AND METHODS OF PLANT CELL GROWING | |
EP3999078A4 (en) | METHODS FOR CULTURING MESENCHYMATOUS STEM CELLS, PRODUCTS RELATED AND THEIR APPLICATIONS | |
EP3962267A4 (en) | COMPOSITION AND METHOD FOR CRYOPRESERVING CELLS | |
EP3511410A4 (en) | MEDIUM FOR THE CULTURE OF STEM CELLS, METHOD FOR THE CULTURE OF STEM CELLS, STEM CELL GROWTH PROMOTER AND COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF | |
EP3845634A4 (en) | COMPOSITION AND METHODS OF PRESERVATION OR CULTURE OF EYE CELLS | |
CA2898601C (en) | Method for separating cell from biological tissue | |
WO2019103528A3 (ko) | 무혈청 배지 조성물 | |
AU2018276376A1 (en) | Cell culture methods | |
WO2019075216A8 (en) | Plectin-1 binding antibodies and uses thereof | |
MX2021011609A (es) | Moduladores de interacciones de proteinas de superficie celular y metodos y composiciones relacionados con estos. | |
EP3954760A4 (en) | CLINICAL GRADE AUTOLOGOUS BRONCHIAL BASAL CELL, TRANSFUSION FORMULATION AND METHOD OF MANUFACTURE | |
EP3967753A4 (en) | PROCESS FOR CULTIVATION OF ALLOGOUS IMMUNITY CELLS, IMMUNITY CELL CULTURE OBTAINED THEREBY AND IMMUNITY CELL THERAPEUTIC THEREFORE | |
EP3460050A4 (en) | CELL CULTURE METHOD, CULTURE MEDIUM AND CULTURE MEDIUM KIT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2019528438 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2017872943 Country of ref document: EP Effective date: 20190624 |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17872943 Country of ref document: EP Kind code of ref document: A2 |